Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 2
1977 4
1978 5
1979 7
1980 1
1981 2
1982 3
1983 2
1984 3
1985 5
1986 11
1987 4
1988 2
1989 2
1990 2
1991 2
1992 3
1993 7
1994 2
1995 2
1996 4
1997 1
1998 2
1999 3
2000 3
2001 7
2002 7
2003 9
2004 17
2005 16
2006 24
2007 29
2008 21
2009 12
2010 10
2011 9
2012 12
2013 11
2014 10
2015 12
2016 23
2017 26
2018 23
2019 12
2020 8
2021 14
2022 10
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 17412741

395 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
Farkouh ME, Kirshner H, Harrington RA, Ruland S, Verheugt FW, Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Gimona A, Matchaba P, Hawkey CJ, Chesebro JH; TARGET Study Group. Farkouh ME, et al. Lancet. 2004 Aug 21-27;364(9435):675-84. doi: 10.1016/S0140-6736(04)16894-3. Lancet. 2004. PMID: 15325832 Clinical Trial.
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.
Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Matchaba P, Gimona A, Hawkey CJ; TARGET Study Group. Schnitzer TJ, et al. Lancet. 2004 Aug 21-27;364(9435):665-74. doi: 10.1016/S0140-6736(04)16893-1. Lancet. 2004. PMID: 15325831 Clinical Trial.
Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment--findings from the Therapeutic Arthritis Research and Gastrointestinal Event Trial.
Hawkey CJ, Weinstein WM, Stricker K, Murphy V, Richard D, Krammer G, Rebuli R. Hawkey CJ, et al. Aliment Pharmacol Ther. 2008 May;27(9):838-45. doi: 10.1111/j.1365-2036.2008.03622.x. Epub 2008 Jan 22. Aliment Pharmacol Ther. 2008. PMID: 18221410 Free article. Clinical Trial.
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM; PRECISION Trial Investigators. Nissen SE, et al. N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593. Epub 2016 Nov 13. N Engl J Med. 2016. PMID: 27959716 Free article. Clinical Trial.
395 results